David Albert Gross, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipid Metabolism | 3 | 2014 | 1887 | 0.520 |
Why?
|
| Triglycerides | 4 | 2013 | 2450 | 0.520 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2014 | 19 | 0.490 |
Why?
|
| Neovascularization, Physiologic | 1 | 2022 | 1350 | 0.490 |
Why?
|
| Ischemia | 1 | 2022 | 1911 | 0.440 |
Why?
|
| Membrane Proteins | 5 | 2013 | 7873 | 0.430 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3455 | 0.330 |
Why?
|
| Lipids | 3 | 2013 | 3302 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 3 | 2014 | 1144 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 1655 | 0.150 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 882 | 0.120 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2014 | 98 | 0.120 |
Why?
|
| Triolein | 1 | 2011 | 8 | 0.110 |
Why?
|
| Micelles | 1 | 2013 | 203 | 0.100 |
Why?
|
| Spodoptera | 1 | 2011 | 153 | 0.100 |
Why?
|
| Inclusion Bodies | 1 | 2013 | 279 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2011 | 354 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2022 | 1184 | 0.100 |
Why?
|
| Binding, Competitive | 1 | 2011 | 1159 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 9387 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1499 | 0.090 |
Why?
|
| Sulfotransferases | 1 | 2009 | 151 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2011 | 1683 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 500 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2010 | 1202 | 0.070 |
Why?
|
| Cell Line | 2 | 2011 | 15994 | 0.070 |
Why?
|
| Animals | 8 | 2022 | 168561 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2022 | 10472 | 0.070 |
Why?
|
| Mice | 5 | 2022 | 81045 | 0.070 |
Why?
|
| Adipocytes | 1 | 2013 | 1182 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1969 | 0.070 |
Why?
|
| Ligands | 1 | 2013 | 3293 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2440 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9410 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 3133 | 0.060 |
Why?
|
| Kinetics | 1 | 2011 | 6474 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3847 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 1884 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4200 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6608 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 2749 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 4187 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 13814 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6454 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5019 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 18112 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2010 | 5454 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3278 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2021 | 437 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 1707 | 0.040 |
Why?
|
| Mutation | 3 | 2011 | 29717 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11695 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4933 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Inositol | 1 | 2012 | 216 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2011 | 100 | 0.020 |
Why?
|
| Humans | 7 | 2021 | 742088 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 230 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 791 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2009 | 414 | 0.020 |
Why?
|
| Phospholipids | 1 | 2012 | 781 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 2009 | 414 | 0.020 |
Why?
|
| Male | 2 | 2022 | 349538 | 0.020 |
Why?
|
| Muscles | 1 | 2011 | 1617 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 1123 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2257 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2751 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13256 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2203 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15530 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2009 | 3127 | 0.010 |
Why?
|
| Epitopes | 1 | 2009 | 2569 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2009 | 1051 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12071 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2896 | 0.010 |
Why?
|
| Glucose | 1 | 2011 | 4391 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
| Mitochondria | 1 | 2011 | 3520 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23387 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57683 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 21821 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 162944 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213127 | 0.000 |
Why?
|
| Female | 1 | 2021 | 379592 | 0.000 |
Why?
|